Immunotherapy in Metastatic NSCLC: Frontline and What’s After Immunotherapy Failure
Luis E. Raez, MD, FACP, FCCP
Targeted Therapy in Non-Squamous NSCLC: Where Are We and What Is Coming Up?
Edgardo S. Santos, MD, FACP
Treatment-Naïve and First Relapse CLL: What Is The Rationale For Treatment Choice?
Javier Pinilla-Ibarz, MD, PhD
Chimeric Antigen Receptor T-cell therapy in 2020: Current Indications
Mohamed A. Kharfan-Dabaja, MD, MBA, FACP
Palliative Care and the Importance of Advanced Care Planning
Sarah Lowry, DNP, ACNP-BC, AOCNP, ACHPH
Natural Disasters: Infamy vs. Nature – What Lessons Can We Learn
Antonia Coello Novello, MD, MPH, DR.PH
